The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Alpha-Synuclein Post-Translational Modifications Quantification Program, 2024Development of anAssay for Quantification of Alpha-synuclein and its Modifications
Study Rationale: Many studies have shown that a protein called alpha-synuclein is abnormal in Parkinson's disease (PD), forming toxic aggregates that move through the brain and cause neuronal cell...
-
Research Grant, 2024Developing an Open-access Repository of High-quality Digital Measurement Tools for Use in Parkinson’s Disease Research and Care
The Library of Digital Measurement Products
Study Rationale: This study will bring together leaders in Parkinson’s disease (PD) and digital health innovation and measurement to develop and maintain...
-
2022: Accelerated Therapeutics Program, 2024(SUPPLEMENT) Innovative Therapies for Parkinson’s Disease Through a Novel, Unexploited Gene Expression Mechanism Rooted in Human Genetics Enabling a Precision-medicine Approach
Study Rationale: Parkinson’s disease (PD) and Alzheimer’s disease (AD) are neurodegenerative disorders caused by an accumulation of protein aggregates that leads to cell death. Genetic studies suggest...
-
Freezing of Gait Program, 2024Use of Neuromodulation to Relieve Gait Freezing in Parkinson’s Disease
Study Rationale: Almost all individuals with Parkinson’s disease (PD) develop episodes of freezing of gait, which is a sudden inability to take a step while walking. Gait freezing can cause falls that...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2024Strengthening Evidence-based Regulatory Decision-making to Address the Impact of Pesticides on Parkinson's Disease Risk
Study Rationale: Parkinson's disease (PD) is a growing global health concern, and recent research suggests that exposure to certain toxic chemicals, such as pesticides, may contribute to its...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2024Study of Multiple Air Pollutants in Parkinson’s Disease (MAP-PD)
Study Rationale: Chemicals in our environment, including some air pollutants, likely contribute to the development of Parkinson’s disease (PD). However, relatively few chemicals have been identified...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.